Replies to post #725472 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

“e stock price at a given moment of time, particularly in the case of a pre-revenue biotech, means nothing”

It for sure does if there is any chance of JV , partial BO etc . The BO historically for a $10B plus buyout has never been more than 10% to 100% premium of the SP/MC .
Usually more in range of 10-50% premium and very rarely close to approx 100% (i.e. double )

[RobotDroid]

None of that matters when at the top you have a POS nonmanagement mute bunch of clowns who cannot communicate with SH.